Galectin Therapeutics Inc

NASDAQ:GALT   9:38:11 AM EDT
2.34
-0.06 (-2.50%)
Earnings Announcements

Galectin Therapeutics Qtrly Loss Per Share $0.14

Published: 11/15/2021 14:01 GMT
Galectin Therapeutics Inc (GALT) - Galectin Therapeutics Inc - Qtrly Loss per Share $0.14.
Galectin- Believes It Has Sufficient Cash to Fund Currently Planned Operations & Research and Development Activities Through at Least March 31, 2023.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.14

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.15

More details on our Analysts Page.